A fourth dose of the COVID-19 vaccine increased humoral immunity among patients with solid and hematologic cancers, according to study results published in JAMA Oncology.

“In addition, we are planning studies on long-COVID-19 and humoral immune responses to adapted vaccines and a fifth vaccination dose, which is also already being considered in immunocompromised individuals,”– researcher Matthias Preusser

Source: healio